Becker's Hospital Review | Healthcare News & Analysis

Author's posts

ACA fraud crackdown could slow signups: 4 things to know

Federal efforts to prevent fraud in the ACA marketplace are yielding positive results, but new restrictions aimed at curbing fraud may complicate the 2024 open enrollment period, KFF Health News reported Nov. 25. 

HHS expands transplant access for people with HIV

HHS has issued a final rule that removes clinical research requirements for kidney and liver transplants from donors with HIV to recipients with HIV. 

HCA Midwest hospital names CNO

Overland Regional Medical Center in Kansas, part of HCA Midwest Health, has named Jim Boyle, MSN, RN, as chief nursing officer, according to a Nov. 25 news release sent to Becker’s. 

OhioHealth CFO shares 3 strategies for financial success

Columbus-based OhioHealth CFO Michael Browning, a 30-year veteran of healthcare finance, has helped six of the eight health systems he’s worked at undergo financial turnarounds. Mr. Browning told Becker’s that while OhioHealth would not be considered a…

Johns Hopkins All Children's plans $62M expansion

St. Petersburg, Fla.-based Johns Hopkins All Children’s Hospital will undergo a $62 million expansion project next year, The Tampa Bay Times reported Nov. 25.

Trinity Health expands virtual nursing to 26 hospitals, 11 states

Livonia, Mich.-based Trinity Health, which has one of the largest and most robust virtual nursing programs in the U.S., has expanded the care model.

Seattle Children's racial discrimination lawsuit trial begins: 7 things to know

A civil trial has commenced to determine whether Seattle Children’s racially discriminated against the former medical director of one of its clinics, The Seattle Times reported Nov. 26.

Cleveland Clinic reverses Q3 operating loss with 1.1% margin

Cleveland Clinic reported an operating income of $43.4 million (1.1% margin) in the third quarter, reversing a $14.9 million operating loss (-0.4% margin) in the same period last year.

Controversial Alzheimer's drug trial halted

Cassava Sciences announced that the phase 3 trial of its Alzheimer’s drug, simufilam, did not meet its primary endpoints. 

Healthcare leaders urge Congress to recognize pharmacists as providers

In a Nov. 25 letter sent to congressional leaders, the Healthcare Leadership Council pressed legislators to restore pandemic-era pharmacist scopes of practice.